MCM
BIOA

Manchester Capital Management’s BioAmber Inc. BIOA Stock Holding History

Manchester Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,000
Closed -$9K – 647
2015
Q2 		$9K Buy
+1,000
New +$9.15K ﹤0.01% 510

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Manchester Capital Management's BIOA Position: Q3 2015 in Review

Manchester Capital Management sold out of BioAmber Inc. (BIOA) in Q3 2015, closing a stake of 1,000 shares — an estimated $9K sold.

Manchester Capital Management first reported a position in BIOA in Q2 2015 and held it in 1 quarter. The position peaked at $9K in Q2 2015. 34 funds tracked by Wall St. Rank hold BIOA as of Q3 2015.

  • Manchester Capital Management reported no remaining BioAmber Inc. position as of Q3 2015 after selling out during the quarter.
  • Manchester Capital Management sold 1,000 BioAmber Inc. shares in Q3 2015, an estimated $9K.
  • Manchester Capital Management first reported a position in BioAmber Inc. in Q2 2015 and held it in 1 quarter.
  • Manchester Capital Management's BioAmber Inc. position peaked at $9K in Q2 2015.
  • 34 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2015.

Based on Manchester Capital Management's 13F filing for Q3 2015, filed 20 Oct 2015.